128 related articles for article (PubMed ID: 30527964)
1. AA amyloidosis associated with morbid obesity (clinical case).
Beridze Vaktangova N; García Moreira V; García Castañón S; Rodríguez Aguilar R; Domínguez Iglesias F
Reumatol Clin (Engl Ed); 2020; 16(6):493-496. PubMed ID: 30527964
[TBL] [Abstract][Full Text] [Related]
2. Renal AA amyloidosis secondary to morbid obesity?
Alsina E; Martin M; Panadés M; Fernández E
Clin Nephrol; 2009 Oct; 72(4):312-4. PubMed ID: 19825338
[TBL] [Abstract][Full Text] [Related]
3. [Multisystemic amyloidosis. Clinical study of 39 patients in Lebanon].
Saba M; Tohmé A; Abadjian G; Haddad F; Ghayad E
Presse Med; 2005 May; 34(9):640-6. PubMed ID: 15988337
[TBL] [Abstract][Full Text] [Related]
4. Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report.
Peces R; Afonso S; Peces C; Nevado J; Selgas R
BMC Med Genet; 2017 Aug; 18(1):97. PubMed ID: 28859624
[TBL] [Abstract][Full Text] [Related]
5. A patient with AL amyloidosis with negative free light chain results.
Milani P; Valentini V; Ferraro G; Basset M; Russo F; Foli A; Palladini G; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):1035-7. PubMed ID: 26677890
[TBL] [Abstract][Full Text] [Related]
6. Predictors of AA amyloidosis in familial Mediterranean fever.
Mukhin NA; Kozlovskaya LV; Bogdanova MV; Rameev VV; Moiseev SV; Simonyan AKh
Rheumatol Int; 2015 Jul; 35(7):1257-61. PubMed ID: 25586652
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever.
Hamanoue S; Suwabe T; Hoshino J; Sumida K; Mise K; Hayami N; Sawa N; Takaichi K; Fujii T; Ohashi K; Yazaki M; Ikeda S; Ubara Y
Mod Rheumatol; 2016 Jul; 26(4):610-3. PubMed ID: 25619282
[TBL] [Abstract][Full Text] [Related]
8. AA amyloidosis is an emerging cause of nephropathy in obese patients.
Stankovic Stojanovic K; Georgin-Lavialle S; Poitou C; Buob D; Amselem S; Grateau G;
Eur J Intern Med; 2017 Apr; 39():e18-e20. PubMed ID: 28214252
[No Abstract] [Full Text] [Related]
9. Obesity is a significant susceptibility factor for idiopathic AA amyloidosis.
Blank N; Hegenbart U; Dietrich S; Brune M; Beimler J; Röcken C; Müller-Tidow C; Lorenz HM; Schönland SO
Amyloid; 2018 Mar; 25(1):37-45. PubMed ID: 29364741
[TBL] [Abstract][Full Text] [Related]
10. Typing of amyloidosis in renal biopsies: diagnostic pitfalls.
Satoskar AA; Burdge K; Cowden DJ; Nadasdy GM; Hebert LA; Nadasdy T
Arch Pathol Lab Med; 2007 Jun; 131(6):917-22. PubMed ID: 17550319
[TBL] [Abstract][Full Text] [Related]
11. Anakinra induces complete remission of nephrotic syndrome in a patient with familial mediterranean fever and amyloidosis.
Sevillano ÁM; Hernandez E; Gonzalez E; Mateo I; Gutierrez E; Morales E; Praga M
Nefrologia; 2016; 36(1):63-6. PubMed ID: 26409501
[TBL] [Abstract][Full Text] [Related]
12. [Amyloidosis of familial Mediterranean fever (FMF)--insights to FMF phenotype II].
Livneh A
Harefuah; 2006 Oct; 145(10):743-5, 782. PubMed ID: 17111710
[TBL] [Abstract][Full Text] [Related]
13. High frequency of amyloid lymphadenopathy in uremic patients.
Güz G; Ozdemir BH; Sezer S; Yakupoglu U; Demirhan B; Ozdemir FN; Haberal M
Ren Fail; 2000; 22(5):613-21. PubMed ID: 11041293
[TBL] [Abstract][Full Text] [Related]
14. [Systemic AA amyloidosis induced by benign neoplasms].
Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
[TBL] [Abstract][Full Text] [Related]
15. [AA amyloidosis: a little-known complication of chronic leg ulcer].
Waton J; Fays-Michel S; Chandeclerc ML; Corby S; Cuny JF; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2008 Feb; 135(2):119-22. PubMed ID: 18342093
[TBL] [Abstract][Full Text] [Related]
16. AA amyloidosis complicating the hereditary periodic fever syndromes.
Lane T; Loeffler JM; Rowczenio DM; Gilbertson JA; Bybee A; Russell TL; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
Arthritis Rheum; 2013 Apr; 65(4):1116-21. PubMed ID: 23280696
[TBL] [Abstract][Full Text] [Related]
17. Colchicine use in isolated renal AA amyloidosis.
Meneses CF; Egües CA; Uriarte M; Belzunegui J; Rezola M
Reumatol Clin; 2015; 11(4):242-3. PubMed ID: 25453598
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
Yamada Y; Ueno T; Irifuku T; Nakashima A; Doi S; Ichinohe T; Masaki T
Clin Nephrol; 2018 Sep; 90(3):232-236. PubMed ID: 29701172
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin-related (AL) amyloidosis.
Husby G
Clin Exp Rheumatol; 1983; 1(4):353-8. PubMed ID: 6442636
[TBL] [Abstract][Full Text] [Related]
20. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type.
Löfberg H; Thysell H; Westman K; Larsen S; Brun C; Gruic V; Grubb A
Acta Pathol Microbiol Immunol Scand A; 1987 Nov; 95(6):357-63. PubMed ID: 3120491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
